Condition: Long COVID · Sponsor: ParagonClinicals Inc.
This will be a six-week, randomized, parallel, two group, open-label design. Patients will be treated with Paragon Novel Metabolic Regulator (PNMR) + standard of care (SOC) or SOC alone for 6 weeks for the treatment of Long COVID. All patients will also be provided with with Dietary \& Lifestyle recommendations specifically designed to enhance immune system function and reduce viral proliferation. Patients will be assessed in the clinic at screening/baseline, 3 and 6 weeks while on treatment, and by telephone at 4 weeks post-treatment. All patients will be asked to fill in a diary to record their daily treatment dosage when being treated with PNMR + SOC or with SOC alone. Primary objective: To evaluate the efficacy of PNMR + (SOC) vs. SOC in the treatment and management of patients with long COVID.
This description comes directly from the study's public registry record.
Samuel H. O. Bock / CSO, BA Environmental Science · 514 998-3935 · sbock@paragonsciences.com
John S Sampalis, PHD Epidemiology · 514 934-6116 · jsampalis@jssresearch.com
Always discuss trial participation with your own doctor first.
| Cardio Health | Brampton, Ontario, Canada | Recruiting |
| Cardio Health | London, Ontario, Canada | Recruiting |
| Cardio Health | Mississauga, Ontario, Canada | Recruiting |
| Cardio Health | North York, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07627815